Indian researchers discovered a specific protein IL-35 for diabetes treatment
Interleukin-35 (IL-35) has emerged as a promising candidate in the field of immunotherapy for Type 1 Diabetes Mellitus (T1DM) and autoimmune diabetes mellitus (AIDM). The therapeutic utility of IL-35 is...